Filtered By:
Infectious Disease: Hepatitis B
Vaccination: Measles Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 93 results found since Jan 2013.
Direct and crowding-out effects of a Hepatitis B vaccination campaign
Econ Hum Biol. 2023 Jul 23;51:101279. doi: 10.1016/j.ehb.2023.101279. Online ahead of print.ABSTRACTWe evaluate the direct and spillover causal effects of a Hepatitis B (HB) vaccination campaign in French schools on the vaccination adherence of the targeted pupils. Using a regression discontinuity design, we show that this campaign created an exogenous shock on vaccination behavior, increasing the HB vaccination rate for children aged 11 and above. At the same time, we show a drop in the measles, mumps, and rubella (MMR) vaccination rate of the targeted pupils and an increase in the parental belief that measles is a benign...
Source: Economics and Human Biology - August 11, 2023 Category: Biology Authors: Cl émentine Garrouste Arthur Juet Anne-Laure Samson Source Type: research
Mapping the timeliness of routine childhood vaccination in The Gambia: A spatial modelling study
CONCLUSIONS: Our approach provides decision-makers with a valuable tool to better understand local patterns of untimely childhood vaccination and identify districts where strengthening vaccine delivery systems could have the greatest impact.PMID:37563051 | DOI:10.1016/j.vaccine.2023.08.004
Source: Vaccine - August 10, 2023 Category: Allergy & Immunology Authors: Oghenebrume Wariri Chigozie Edson Utazi Uduak Okomo C Jessica E Metcalf Malick Sogur Sidat Fofana Kris A Murray Chris Grundy Beate Kampmann Source Type: research
Recent Progress and Challenges in the Development of Edible Vaccines Produced by Genetically Modified Plants
This article includes important uses, production, host plants, benefits, drawbacks, mechanism of action, and many regulatory difficulties related to edible vaccines. In this article, we have discussed the most recent developments and successes with edible and intradermal vaccines in terms of the system used for immunogen production, the molecular properties of these vaccines, and their ability to generate a protective systemic and mucosal response.PMID:37537938 | DOI:10.2174/1389203724666230804095716
Source: Current Protein and Peptide Science - August 4, 2023 Category: Biochemistry Authors: Smita Singh Pranjal Kumar Singh Kapil Sachan Sakshi Garg Alok Nath Sharma Source Type: research
Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030
Vaccine. 2023 Aug 1:S0264-410X(23)00854-X. doi: 10.1016/j.vaccine.2023.07.033. Online ahead of print.ABSTRACTBACKGROUND: The Immunization Agenda 2030 (IA2030) Impact Goal 1.1. aims to reduce the number of future deaths averted through immunization in the next decade. To estimate the potential impact of the aspirational coverage targets for IA2030, we developed an analytical framework and estimated the number of deaths averted due to an ambitious vaccination coverage scenario from 2021 to 2030 in 194 countries.METHOD: A demographic model was used to determine annual age-specific mortality estimates associated with vaccine c...
Source: Vaccine - August 3, 2023 Category: Allergy & Immunology Authors: Austin Carter William Msemburi So Yoon Sim Katy A M Gaythorpe Philipp Lambach Ann Lindstrand Raymond Hutubessy Source Type: research
Status of New Vaccine Introduction - Worldwide, 2016-2021
This report describes the status of introductions globally for eight World Health Organization (WHO)-recommended new and underutilized vaccines, comprising 10 individual vaccine antigens. By 2021, among 194 countries worldwide, 33 (17%) provided all of these 10 WHO-recommended antigens as part of their routine immunization schedules; only one low-income country had introduced all of these recommended vaccines. Universal hepatitis B birth dose; human papillomavirus vaccine; rotavirus vaccine; and diphtheria, tetanus, and pertussis-containing vaccine first booster dose have been introduced by 57%, 59%, 60%, and 72% of all co...
Source: MMWR Morb Mortal Wkl... - July 6, 2023 Category: Epidemiology Authors: Gurpreet Kaur Rebecca M Casey Jaymin C Patel Paul Bloem Jenny A Walldorf Terri B Hyde Source Type: research
